Cargando…
FOXP4‐AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer
Ovarian cancer (OV) is the main cause of deaths worldwide in female reproductive system malignancies. Enhancer RNAs (eRNAs) are derived from the transcription of enhancers and has attracted increasing attention in cancers recently. However, the biological functions and clinical significance of eRNAs...
Autores principales: | Hua, Tian, Tian, Yun-jie, Wang, Rui-min, Zhao, Cai-fen, Kong, Yun-hong, Tian, Rui-qing, Wang, Wei, Ma, Li-xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150160/ https://www.ncbi.nlm.nih.gov/pubmed/33870423 http://dx.doi.org/10.1042/BSR20204008 |
Ejemplares similares
-
ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021) -
Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia
por: Wang, Cui-zhu, et al.
Publicado: (2022) -
Prognostic implications of PPL expression in ovarian cancer
por: Hua, Tian, et al.
Publicado: (2022) -
LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer
por: Wang, Qingqing, et al.
Publicado: (2021) -
Construction of a novel prognostic-predicting model correlated to ovarian cancer
por: Tang, Weichun, et al.
Publicado: (2020)